14 results found.

Cerebral Palsy, or Spasticity Clinical Trial using IncobotulinumtoxinA (8 Units per kg body weight); IncobotulinumtoxinA (6 Units per kg body weight); IncobotulinumtoxinA (2 Units per kg body weight)

Merz Pharmaceuticals GmbH - Recruiting 2 years to 17 years.
- Prospective, Multicenter, Randomized, Double-blind, Parallel-group, Dose-response Study of Three Doses Xeominr (incobotulinumtoxinA, NT 201) for the Treatment of Upper Limb Spasticity Alone or Combined Upper and Lower Limb Spasticity in Children and Adolescents (Age 2 - 17 Years) With Cerebral Palsy.
IncobotulinumtoxinA (8 Units per kg body weight); IncobotulinumtoxinA (6 Units per kg body weight); IncobotulinumtoxinA (2 Units per kg body weight)

Lower Limb Spasticity Due to Cerebral Palsy Clinical Trial using IncobotulinumtoxinA (16 Units per kg body weight); IncobotulinumtoxinA (12 Units per kg body weight); IncobotulinumtoxinA (4 Units per kg body weight)

Merz Pharmaceuticals GmbH - Recruiting 2 years to 17 years.
- Prospective, Multicenter, Randomized, Double-blind, Parallel-group, Dose-response Study of Three Doses Xeominr (incobotulinumtoxinA, NT 201) for the Treatment of Lower Limb Spasticity in Children and Adolescents (Age 2 - 17 Years) With Cerebral Palsy.
IncobotulinumtoxinA (16 Units per kg body weight); IncobotulinumtoxinA (12 Units per kg body weight); IncobotulinumtoxinA (4 Units per kg body weight)

Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due Clinical Trial using IncobotulinumtoxinA (16-20 Units per kg body weight)

Merz Pharmaceuticals GmbH - Recruiting 2 years to 17 years.
- Open-label, Non-controlled, Multicenter Long-term Study to Investigate the Safety and Efficacy of Xeominr (Incobotulinumtoxin A, NT 201) for the Treatment of Spasticity of the Lower Limb(s) or of Combined Spasticity of Upper and Lower Limb in Children and Adolescents (Age 2 - 17 Years) With Cerebral Palsy.
IncobotulinumtoxinA (16-20 Units per kg body weight)

Cerebral Palsy, Children, or Adolescents Clinical Trial using Physical Exercise

National Institutes of Health Clinical Center (CC) - Recruiting 5 years to 17 years.
- Physical, Functional and Neurological Effects of Two Lower Extremity Exercise Programs in Children With Cerebral Palsy.
Physical Exercise

Cerebral Palsy Clinical Trial using Sativex; Placebo

GW Pharmaceuticals Ltd. - Recruiting 8 years to 18 years.
- The Efficacy, Safety and Tolerability of Sativex as an Adjunctive Treatment to Existing Anti-spasticity Medications in Children Aged 8 to 18 Years With Spasticity Due to Cerebral Palsy or Traumatic Central Nervous System Injury Who Have Not Responded Adequately to Their Existing Anti-spasticity Medications: a Parallel Group Randomised, Double-blind, Placebo-controlled Study Followed by a 24-week Open Label Extension Phase.
Sativex; Placebo

Cerebral Palsy Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 5 years to 17 years.
- Evaluating an Extension Assist Knee Ankle Foot Orthosis to Improve Crouch Gait in Cerebral Palsy.

Cerebral Palsy, Preterm Birth, or Development Clinical Trial using Infant Aquatics; Infant Massage

Sheba Medical Center - Recruiting N/A to 4 Weeks.
- The Effect of Infant Aquatics for Neurodevelopment of Premature Infants.
Infant Aquatics; Infant Massage

Cerebral Palsy Clinical Trial using SAFO worn or on

Seattle Children's Hospital - Recruiting 2 years to 9 years.
- Relationship of Orthotics to Activity and Participation in Children With Cerebral Palsy.
SAFO worn or on

Pediatric Stroke, Cerebral Palsy, or Chronic Hemiparesis Clinical Trial using Repetitive Transcranial Magnetic Stimulation

Children's Hospital Medical Center, Cincinnati - Recruiting 10 years to 20 years.
- Motor Control Enhancement Through Repetitive Transcranial Magnetic Stimulation Plus Rehabilitation in Hemiparetic Cerebral Palsy and Stroke.
Repetitive Transcranial Magnetic Stimulation

Cerebral Palsy Clinical Trial using Autologous Stem Cells

The University of Texas Health Science Center, Houston - Recruiting 2 years to 10 years.
- Autologous Cell Therapies for Cerebral Palsy-Chronic (ACT for CP).
Autologous Stem Cells

Orthopedic Complications in Cerebral Palsy Clinical Trial

Hospices Civils de Lyon - Recruiting 3 years to 10 years.
- Longitudinal Study of a Children Population With Bilateral Severe Cerebral Palsy: Incidence and Evolution of Orthopaedic Complications and Pain Related With These Complications..

Osteoarthritis, Osteosarcoma, Scoliosis, or Cerebral Palsy Clinical Trial

University of Florida - Recruiting N/A or older.
- Orthopaedic Data Bank; Collection and Storage of Data Relating to Orthopaedic Disorders.

Cerebral Palsy, Hemiplegia, or Children Clinical Trial using Baby-CIMT; Baby-Massage

Karolinska Institutet - Recruiting 3 Months to 8 Months.
- The Efficacy of Constraint Induced Movement Therapy for Babies (Baby-CIMT) in Infants Below 12 Month With Risk of Developing Unilateral Cerebral Palsy, a Study Protocol of a Randomized Controlled Trial.
Baby-CIMT; Baby-Massage

Muscle Spasticity Clinical Trial using Botulinum Toxin Type A

Medy-Tox - Recruiting 2 years to 18 years.
- Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Safety and Efficacy of MEDITOXINr in Children With Cerebral Palsy.
Botulinum Toxin Type A